{"text": "gild still active in bd strategy is to bring mid to early stage assets in house order of priority is virology followed by oncology and then inflammation and looking at good assets in rheum ibd and fibrosis however they seemed less interested in late stage deals sgmo tregs"}
{"text": "wells fargo met with gild s chief commercial officer johanna mercier and svp of corporate development devang bhuva and had a good discussion on growth prospects and biz dev"}
{"text": "gild rcus thinks their drug has demonstrated that tigit is active and the trials are designed in a way to show this head to head vs pembro thinks that the os superiority bar is 30 improvement over any non keytruda pd l 1 and 20 improvement vs keytruda in their doc checks"}
{"text": "virology o o gild"}
{"text": "good dividend stocks and optionstrading optionspremiums stocks are having a good day dvn kmi wba xom xle gild nem click on image for better view"}
{"text": "2023 03 02 short sale volume not short interest for xlp is 67 lkco 63 gild 53 xme 73 xle 63"}
